307 related articles for article (PubMed ID: 33152902)
1. Omics technologies for improved diagnosis and treatment of colorectal cancer: Technical advancement and major perspectives.
Dalal N; Jalandra R; Sharma M; Prakash H; Makharia GK; Solanki PR; Singh R; Kumar A
Biomed Pharmacother; 2020 Nov; 131():110648. PubMed ID: 33152902
[TBL] [Abstract][Full Text] [Related]
2. Multi-Omics Approaches in Colorectal Cancer Screening and Diagnosis, Recent Updates and Future Perspectives.
Ullah I; Yang L; Yin FT; Sun Y; Li XH; Li J; Wang XJ
Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428637
[TBL] [Abstract][Full Text] [Related]
3. Multi-omics insights into the interplay between gut microbiota and colorectal cancer in the "microworld" age.
Wang AJ; Song D; Hong YM; Liu NN
Mol Omics; 2023 May; 19(4):283-296. PubMed ID: 36916422
[TBL] [Abstract][Full Text] [Related]
4. Towards personalized medicine of colorectal cancer.
Aziz MA; Yousef Z; Saleh AM; Mohammad S; Al Knawy B
Crit Rev Oncol Hematol; 2017 Oct; 118():70-78. PubMed ID: 28917272
[TBL] [Abstract][Full Text] [Related]
5. Analyzing the Secretome of Gut Microbiota as the Next Strategy For Early Detection of Colorectal Cancer.
Megat Mohd Azlan PI; Chin SF; Low TY; Neoh HM; Jamal R
Proteomics; 2019 May; 19(10):e1800176. PubMed ID: 30557447
[TBL] [Abstract][Full Text] [Related]
6. Culturing the human microbiota and culturomics.
Lagier JC; Dubourg G; Million M; Cadoret F; Bilen M; Fenollar F; Levasseur A; Rolain JM; Fournier PE; Raoult D
Nat Rev Microbiol; 2018 May; 16():540-550. PubMed ID: 29937540
[TBL] [Abstract][Full Text] [Related]
7. Progress of gut microbiome and its metabolomics in early screening of colorectal cancer.
Zhou L; Jiang Z; Zhang Z; Xing J; Wang D; Tang D
Clin Transl Oncol; 2023 Jul; 25(7):1949-1962. PubMed ID: 36790675
[TBL] [Abstract][Full Text] [Related]
8. Proteomics, genomics and transcriptomics: their emerging roles in the discovery and validation of colorectal cancer biomarkers.
Wang K; Huang C; Nice EC
Expert Rev Proteomics; 2014 Apr; 11(2):179-205. PubMed ID: 24611605
[TBL] [Abstract][Full Text] [Related]
9. Integrated microbiome and metabolome analysis reveals a novel interplay between commensal bacteria and metabolites in colorectal cancer.
Yang Y; Misra BB; Liang L; Bi D; Weng W; Wu W; Cai S; Qin H; Goel A; Li X; Ma Y
Theranostics; 2019; 9(14):4101-4114. PubMed ID: 31281534
[No Abstract] [Full Text] [Related]
10. Intestinal microbiota and colorectal carcinoma: Implications for pathogenesis, diagnosis, and therapy.
Montalban-Arques A; Scharl M
EBioMedicine; 2019 Oct; 48():648-655. PubMed ID: 31631043
[TBL] [Abstract][Full Text] [Related]
11. Integration of the Microbiome, Metabolome and Transcriptomics Data Identified Novel Metabolic Pathway Regulation in Colorectal Cancer.
Bisht V; Nash K; Xu Y; Agarwal P; Bosch S; Gkoutos GV; Acharjee A
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071236
[TBL] [Abstract][Full Text] [Related]
12. Untangling determinants of gut microbiota and tumor immunologic status through a multi-omics approach in colorectal cancer.
Zhang SL; Cheng LS; Zhang ZY; Sun HT; Li JJ
Pharmacol Res; 2023 Feb; 188():106633. PubMed ID: 36574857
[TBL] [Abstract][Full Text] [Related]
13. Alterations in the Gut Microbiota and Their Metabolites in Colorectal Cancer: Recent Progress and Future Prospects.
Li J; Zhang AH; Wu FF; Wang XJ
Front Oncol; 2022; 12():841552. PubMed ID: 35223525
[TBL] [Abstract][Full Text] [Related]
14. Precision medicine in colorectal cancer: Leveraging multi-omics, spatial omics, and artificial intelligence.
Xu Z; Li W; Dong X; Chen Y; Zhang D; Wang J; Zhou L; He G
Clin Chim Acta; 2024 Jun; 559():119686. PubMed ID: 38663471
[TBL] [Abstract][Full Text] [Related]
15. Omics technologies in poultry health and productivity - part 1: current use in poultry research.
Dehau T; Ducatelle R; Van Immerseel F; Goossens E
Avian Pathol; 2022 Oct; 51(5):407-417. PubMed ID: 35675291
[TBL] [Abstract][Full Text] [Related]
16. Challenges and Perspective in Integrated Multi-Omics in Gut Microbiota Studies.
Daliri EB; Ofosu FK; Chelliah R; Lee BH; Oh DH
Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33671370
[TBL] [Abstract][Full Text] [Related]
17. The human gut microbiome and its dysfunctions through the meta-omics prism.
Mondot S; Lepage P
Ann N Y Acad Sci; 2016 May; 1372(1):9-19. PubMed ID: 26945826
[TBL] [Abstract][Full Text] [Related]
18. Use of omic technologies in early life gastrointestinal health and disease: from bench to bedside.
Beck LC; Granger CL; Masi AC; Stewart CJ
Expert Rev Proteomics; 2021 Apr; 18(4):247-259. PubMed ID: 33896313
[No Abstract] [Full Text] [Related]
19. Biomarker discovery by proteomics-based approaches for early detection and personalized medicine in colorectal cancer.
Corbo C; Cevenini A; Salvatore F
Proteomics Clin Appl; 2017 May; 11(5-6):. PubMed ID: 28019089
[TBL] [Abstract][Full Text] [Related]
20. Gut microbiome and its meta-omics perspectives: profound implications for cardiovascular diseases.
Xu J; Yang Y
Gut Microbes; 2021; 13(1):1936379. PubMed ID: 34170211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
